Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors

NCT07095868 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Selected Types of Solid Tumor

Interventions

BIOLOGICAL: EVM14
COMBINATION_PRODUCT: Pembrolizumab

Sponsor

Everest Medicines (Beijing) Co., Ltd.